Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil
Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil is a paper indexed in PICO Portal from OpenAlex.
How many citations does Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil have?
Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil has 30 citations in the OpenAlex counts PICO Portal stores.
When was Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil published?
Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil has 2018 year in the PICO Portal index.
What is the open-access status of Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil?
Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil has closed oa status in the PICO Portal index.
What is the DOI of Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil?
The DOI for Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil is on the source record.
What is the PMID of Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil?
The PMID for Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil is on the source record.
What is the OpenAlex record for Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil?
The OpenAlex for Development and <i>in vitro</i> characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil is on the source record.